What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Anthony Lembo focuses on Internal medicine, Irritable bowel syndrome, Gastroenterology, Placebo and Randomized controlled trial.
His study ties his expertise on Surgery together with the subject of Internal medicine.
His Irritable bowel syndrome research is multidisciplinary, incorporating perspectives in Meta-analysis, Physical therapy, Clinical trial and Eluxadoline.
His research in Gastroenterology intersects with topics in Defecation, University medical and General surgery.
Many of his studies on Placebo involve topics that are commonly interrelated, such as Bloating.
His Randomized controlled trial research incorporates elements of Acupuncture and Quality of life.
His most cited work include:
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis (1254 citations)
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome (834 citations)
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation (684 citations)
What are the main themes of his work throughout his whole career to date?
Anthony Lembo mainly focuses on Internal medicine, Gastroenterology, Irritable bowel syndrome, Constipation and Placebo.
His research in the fields of Diarrhea, Abdominal pain and Linaclotide overlaps with other disciplines such as In patient.
His studies in Gastroenterology integrate themes in fields like Gastrointestinal agent and Tolerability, Adverse effect.
His Irritable bowel syndrome research includes elements of Clinical trial, Eluxadoline, Quality of life, Intensive care medicine and Physical therapy.
His Constipation study incorporates themes from Anesthesia and Defecation.
The various areas that Anthony Lembo examines in his Placebo study include Randomized controlled trial and Surgery.
He most often published in these fields:
- Internal medicine (67.87%)
- Gastroenterology (45.50%)
- Irritable bowel syndrome (44.47%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.87%)
- Irritable bowel syndrome (44.47%)
- Gastroenterology (45.50%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Irritable bowel syndrome, Gastroenterology, Diarrhea and Constipation.
His study in Placebo extends to Internal medicine with its themes.
His research integrates issues of Insomnia, Activities of daily living, Disease, Hepatology and Depression in his study of Irritable bowel syndrome.
His Gastroenterology study combines topics in areas such as Feces, Adverse effect and Antibiotics.
In his study, Pain severity is inextricably linked to Rifaximin, which falls within the broad field of Diarrhea.
Anthony Lembo has researched Constipation in several fields, including Odds ratio, Bloating, Defecation and Pelvic floor.
Between 2017 and 2021, his most popular works were:
- The international anorectal physiology working group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function (36 citations)
- Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome. (27 citations)
- Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Internal medicine, Irritable bowel syndrome, Placebo, Gastroenterology and Constipation.
His Internal medicine research is multidisciplinary, incorporating perspectives in National Health and Nutrition Examination Survey and Double blind.
Anthony Lembo has included themes like Disease, Hepatology, Diarrhea, Abdominal pain and Depression in his Irritable bowel syndrome study.
His work deals with themes such as Gastrointestinal agent, Naloxegol, Gastroparesis and Intention-to-treat analysis, which intersect with Placebo.
As part of the same scientific family, Anthony Lembo usually focuses on Gastroenterology, concentrating on Tenapanor and intersecting with Constipation predominant irritable bowel syndrome.
Anthony Lembo focuses mostly in the field of Constipation, narrowing it down to topics relating to Clinical trial and, in certain cases, Odds ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
